Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/38850
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLim S.S.en
dc.contributor.authorPattie P.R.en
dc.contributor.authorHertzog P.J.en
dc.contributor.authorDe Weerd N.A.en
dc.contributor.authorMatthews A.Y.en
dc.contributor.authorVivian J.P.en
dc.contributor.authorBourke N.M.en
dc.contributor.authorRossjohn J.en
dc.date.accessioned2021-05-14T13:15:58Zen
dc.date.available2021-05-14T13:15:58Zen
dc.date.copyright2017en
dc.date.created20170517en
dc.date.issued2017-05-17en
dc.identifier.citationJournal of Biological Chemistry. 292 (18) (pp 7554-7565), 2017. Date of Publication: 05 May 2017.en
dc.identifier.issn0021-9258en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/38850en
dc.description.abstractThe interaction of IFN-beta with its receptor IFNAR1 (interferon alpha/beta receptor subunit 1) is vital for host-protective anti-viral and anti-proliferative responses, but signaling via this interaction can be detrimental if dysregulated. Whereas it is established that IFNAR1 is an essential component of the IFNAR signaling complex, the key residues underpinning the IFN-beta-IFNAR1 interaction are unknown. Guided by the crystal structure of the IFN-beta-IFNAR1 complex, we used truncation variants and site-directed mutagenesis to investigate domains and residues enabling complexation of IFN-beta to IFNAR1. We have identified an interface on IFNAR1-subdomain-3 that is differentially utilized by IFN-beta and IFN-alpha for signal transduction. We used surface Plasmon resonance and cell-based assays to investigate this important IFN-beta binding interface that is centered on IFNAR1 residues Tyr240 and Tyr274 binding the C and N termini of the Band Chelices of IFN-beta, respectively. Using IFNAR1 and IFN-beta variants, we show that this interface contributes significantly to the affinity of IFN-beta for IFNAR1, its ability to activate STAT1, the expression of interferon stimulated genes, and ultimately to the anti-viral and anti-proliferative properties of IFN-beta. These results identify a key interface created by IFNAR1 residues Tyr240 and Tyr274 interacting with IFN-beta residues Phe63, Leu64, Glu77, Thr78, Val81, and Arg82 that underlie IFN-beta-IFNAR1-mediated signaling and biological processes.Copyright © 2017 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.en
dc.languageenen
dc.languageEnglishen
dc.publisherAmerican Society for Biochemistry and Molecular Biology Inc. (9650 Rockville Pike, Bethesda MD 20814, United States)en
dc.relation.ispartofJournal of Biological Chemistryen
dc.titleA hot spot on interferon alpha/beta receptor subunit 1 (IFNAR1) underpins its interaction with interferon-beta and dictates signaling.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1074/jbc.M116.773788en
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid28289093 [http://www.ncbi.nlm.nih.gov/pubmed/?term=28289093]en
dc.identifier.source615956752en
dc.identifier.institution(De Weerd, Matthews, Pattie, Bourke, Lim, Hertzog) Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, VIC 3168, Australia (De Weerd, Matthews, Bourke, Lim, Hertzog) Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, VIC 3168, Australia (Vivian, Rossjohn) Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia (Vivian, Rossjohn) Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia (Rossjohn) Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdomen
dc.description.addressN.A. De Weerd, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, VIC 3168, Australia. E-mail: nicole.deweerd@hudson.org.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2017 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailDe Weerd N.A.; nicole.deweerd@hudson.org.au Hertzog P.J.; paul.hertzog@hudson.org.auen
dc.description.grantNo: APP1070782 Organization: (NHMRC) *National Health and Medical Research Council* Country: Australia No: APP1126524 Organization: (NHMRC) *National Health and Medical Research Council* Country: Australiaen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
Appears in Collections:Articles
Show simple item record

Page view(s)

30
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.